Drug Trial Radar · NCT00871325
Effect of TU-100 on Gastrointestinal and Colonic Transit in Humans
Last checked: Nov 19, 2026Latest source record: Jan 14, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Jun 2009
Primary completion
Dec 2009
Study completion Jan 2010
Sponsor
- Lead sponsor
- Tsumura USAIndustry
- Sponsor type
- Industry
- Collaborators
- Cato Research
- First posted
- Mar 30, 2009
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the dose related effects of orally administered TU-100, a botanical agent that modulates gastrointestinal nerves, on gastrointestinal motility and colonic transit of solids.
Conditions
- Postoperative Ileus
Interventions
Daikenchuto (TU-100)Drug
Subjects will receive 2.5g TID (7.5g/day) of TU-100. Dosage form is a granule. Subject will take a daily dose divided three times a day for 5 days.
Daikenchuto (TU-100)Drug
Subjects will receive 5g TID (15g/day) of TU-100. Dosage form is a granule. Subject will take a daily dose divided three times a day for 5 days.
PlaceboDrug
Subjects will receive daily dose of TU-100 placebo. Dosage form is a granule. Subject will take a daily dose divided three times a day for 5 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Gastric emptying of solidTime frame: 1 hr, 2 hrs, 3 hrs, 4 hrs, 5 hrs, 6 hrs, 8 hrs, 24 hrs, 48 hrs
- Colonic geometric center at 24 hoursTime frame: 4 hrs, 8 hrs, and 24 hrs
- Ascending colon emptyingTime frame: 1 hr, 2 hrs, 3 hrs, 4 hrs, 5 hrs, 6 hrs, 8 hrs, 24 hrs
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Mayo Clinic, Rochester Methodist CRU
Rochester, Minnesota
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.